Nutlin-3a induces KRAS mutant/p53 wild type lung cancer specific methuosis-like cell death that is dependent on GFPT2
Abstract Background Oncogenic KRAS mutation, the most frequent mutation in non-small cell lung cancer (NSCLC), is an aggressiveness risk factor and leads to the metabolic reprogramming of cancer cells by promoting glucose, glutamine, and fatty acid absorption and glycolysis. Lately, sotorasib was ap...
Main Authors: | Dasom Kim, Dongwha Min, Joohee Kim, Min Jung Kim, Yerim Seo, Byung Hwa Jung, Seung‑Hae Kwon, Hyunju Ro, Seoee Lee, Jason K. Sa, Ji-Yun Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-023-02922-8 |
Similar Items
-
Tanshinlactone triggers methuosis in breast cancer cells via NRF2 activation
by: Wanjun Lin, et al.
Published: (2025-01-01) -
The Dual Role of Macropinocytosis in Cancers: Promoting Growth and Inducing Methuosis to Participate in Anticancer Therapies as Targets
by: Shaojuan Song, et al.
Published: (2021-01-01) -
Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation
by: E. Merit Reyes-Reyes, et al.
Published: (2015-08-01) -
Tubeimoside 1 Acts as a Chemotherapeutic Synergist via Stimulating Macropinocytosis
by: Xianling Gong, et al.
Published: (2018-09-01) -
Corrigendum: Tubeimoside 1 Acts as a Chemotherapeutic Synergist via Stimulating Macropinocytosis
by: Xianling Gong, et al.
Published: (2021-07-01)